Lisata Therapeutics: A Triumph in the Stock Market
Lisata Therapeutics: A Triumph in the Stock Market
The Potential of Certepetide Unveiled Lisata Therapeutics, Inc.’s stock, symbolized as LSTA on the NASDAQ, has witnessed a remarkable surge of 33.7% year to date (YTD). This resurgence comes amidst a backdrop of a general industry retraction of 2.7%. A Silver Lining for Cancer Treatment The driving force behind this stock momentum is the promising ...












